07 Apr 2019

The Desperate Rearguard Action the British Medical Establishment is Fighting Against Cannabis

This Arrogant Man Must Face Tough Questions About his Stance on Cannabis, his Financial Interests and his Breathtaking Hypocrisy. Professor Finbar O'Callaghan introduced himself at the recent oral evidence session of the Health and Social Care Committee in these terms: "My name is Professor Finbar O'Callaghan and I am here as president of the British Paediatric Neurology Association which is the association which represents all paediatric neurologists in the UK. I'm also a consultant paediatric neurologist at...

15 Oct 2016

The British Medical Journal (BMJ) Features The CLEAR Medicinal Cannabis Campaign.

"Muddled thinking" over cannabis leaves patients in limbo, warn campaigners BMJ 2016; 355 doi: http://dx.doi.org/10.1136/bmj.i5556 (Published 14 October 2016) Cite this as: BMJ 2016;355:i5556 Download PDF here Companies selling cannabis based products have been told to remove them from the market within 28 days, after a review by the Medicines and Healthcare Products Regulatory Agency (MHRA) determined that they were medicinal products. Campaigners for cannabis law reform welcomed the recognition that cannabidiol (CBD) had medicinal properties but warned that...

17 Sep 2016

CLEAR’s Submission To The Parliamentary Inquiry Into Medicinal Cannabis.

This was the response that CLEAR submitted to the APPG in February 2016.  In March 2016, Roland Gyallay-Pap, then managing director of CLEAR and Peter Reynolds, president, were called to give oral evidence to the Inquiry. A PDF copy of this document may be downloaded here. A copy of the Powerpoint presentation delivered by CLEAR at the oral evidence hearing can be downloaded here.   Introduction In June 2015 the All-Party Parliamentary Group for Drug Policy Reform (APPG) published a short report arguing for a rescheduling of...

29 Aug 2016

Home Secretary Invites CLEAR To ‘Enter A Dialogue’ On Cannabis Law Reform.

In a letter dated 15th August 2016, Amber Rudd, the new Home Secretary, has invited CLEAR to raise "any queries and concerns" about present UK policy on cannabis. This is the first time since 2006, with Charles Clarke, that the UK cannabis campaign has had any direct contact with a serving Home Secretary.  It reflects the reality, now recognised in government, that changes in cannabis policy are imminent. In...

23 Apr 2016

CLEAR and GroGlo Establish First UK Clinical Trials on Cannabis for Chronic Pain.

CLEAR has formed a partnership with the research arm of GroGlo, a UK-based manufacturer of high power, LED, horticultural grow lighting. The plan is to grow cannabis under a Home Office licence for the production of cannabis oil, both as a dietary supplement and for the development of medical products.  To begin with, a low-THC crop of industrial hemp will be planted.  We will be using the finola strain, originally developed in Finland and known for its short stature and early flowering. Unlike hemp grown for fibre, finola...